Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Diabetology International|January 13, 2023
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetesMasato Kase, Toshie Iijima, Takafumi Niitani, et al.Biochemical and Biophysical Research Communications|September 22, 2009
Isolation of a novel leptin receptor gene promoter preferentially functioning in neuronal cellsTetsurou Satoh, Satoshi Yoshino, Akiko Katano, et al.International Journal of Cardiology|February 8, 2021
Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterolTeruo Jojima, Shintaro Sakurai, Sho Wakamatsu, et al.Clinics (Sao Paulo, Brazil)|November 14, 2025
Effects of pemafibrate (a selective PPAR-α agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLDKanako Kato, Teruo Jojima, Dai Tanuma, et al.Journal of Diabetes and Its Complications|February 19, 2021
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosisMasaaki Sagara, Toshie Iijima, Masato Kase, et al.International Journal of Clinical Practice|August 13, 2021
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitorsToshie Iijima, Soichiro Hosonuma, Hidetaka Kurai, et al.Diabetology International|August 5, 2024
Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetesTomohisa Kunii, Isao Usui, Teruo Jojima, et al.Endocrine Journal|March 7, 2022
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intoleranceTeruo Jojima, Toshimitsu Shinzawa, Eriko Ohira, et al.Biochemical and Biophysical Research Communications|June 27, 2009
Roles of proteasomal 19S regulatory particles in promoter loading of thyroid hormone receptorTetsurou Satoh, Takahiro Ishizuka, Satoshi Yoshino, et al.Postgraduate Medicine|April 25, 2024
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetesYoshimasa Aso, Toshie Iijima, Teruo Jojima, et al.Pageof 6